mRNA– tag –
-
Precision RNA Delivery: Preclinical Research Focuses on Targeted LNP Platforms Beyond Hepatic Uptake
jobRxiv USA Overview Preclinical research in LNP-based RNA delivery is prioritizing strategies to overcome inherent liver tropism and achieve targeted delivery to specific cell populations. The goal is to develop and optimize advanced na... -
Theranostic Lipid-Based Nanoparticles for Cancer Treatment: Integrating Diagnostics and Enhanced Drug Delivery
ACS Applied Nano Materials USA Overview This review highlights advancements in lipid-based nanoparticles (LNPs) as theranostic platforms for cancer treatment, integrating therapeutic payloads with imaging agents for real-time monitoring ... -
Translational Progress in Lipid Nanoparticle Drug Delivery Systems for Cancer Therapy: Current Status and Future Horizons
PMC (PubMed Central) International Overview This review article comprehensively examines lipid nanoparticles (LNPs) as highly adaptable nanocarrier systems for cancer therapy and diagnostics. LNPs leverage structural flexibility, biocomp... -
SelectBIO to Host Lipid Nanoparticles (LNPs) Asia/Pacific 2026: Driving mRNA Delivery Innovations
SelectBIO Conferences UK Overview SelectBIO Conferences will host the 'Lipid Nanoparticles (LNPs) Asia/Pacific 2026' event, focusing on LNPs, extracellular vesicles, exosomes, and Japanese research. The conference will primarily address ... -
The Future of Healing: Gene Therapy in 2026 Navigates CRISPR Advances and Access Challenges
薬事日報 Japan Overview By 2026, gene therapy is undergoing a paradigm shift, moving towards direct repair or replacement of disease-causing genes. CRISPR-based in vivo editing shows early clinical promise, pushing the vision of single-i... -
Advanced Lipid Nanoparticles Revolutionize Nucleic Acid and Gene-Editing Therapeutic Delivery
PMC (PubMed Central) USA Overview Lipid nanoparticles (LNPs) are becoming indispensable for efficient intracellular delivery of nucleic acid, mRNA, and gene-editing therapeutics, shielding them from degradation in circulation. Proven eff... -
Nanomedicine Shifts to Industrial-Scale Production in 2026, Driven by Quality by Design and AI
NanoApps Medical Netherlands Overview Experts predict 2026 as the pivotal year for nanomedicine's transition from proof-of-concept to reliable industrial-scale production. This shift emphasizes "Quality by Design" principles, integrating...
